We are live on
!
Find out more
PCM
Pinz Capital Management Portfolio holdings
AUM
$55.2M
1-Year Est. Return
15.31%
This Fund
S&P 500
This Quarter
Est. Return
+46.84%
1 Year Est. Return
-15.31%
3 Year Est. Return
+198.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
+$180M
(+472%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
72.26%
Top 10 Holdings %
Top 10 Hldgs %
19.36%
Holding
227
New
105
Increased
2
Reduced
4
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$4.98M |
| 2 |
ONEM
1Life Healthcare
ONEM
|
+$4.82M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$4.46M |
| 4 |
PG&E
PCG
|
+$4.35M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$3.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eHealth
EHTH
|
+$2.65M |
| 2 |
Carvana
CVNA
|
+$2.45M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$2.44M |
| 4 |
Freshpet
FRPT
|
+$2.16M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$1.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.7% |
| 2 | Technology | 15.04% |
| 3 | Industrials | 9.87% |
| 4 | Real Estate | 8.86% |
| 5 | Consumer Discretionary | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
76
DELISTED
Avidity Biosciences
RNAM
| $1.41M | 0.65% |
+50,000
| New | +$1.44M |
|
77
ADC Therapeutics
ADCT
$144M
| $1.41M | 0.64% |
+30,000
| New | +$1.14M |
|
78
BILL Holdings
BILL
$4.78B
| $1.39M | 0.63% |
+15,350
| New | +$988K |
|
|
FMTX
79
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $1.38M | 0.63% |
+29,700
| New | +$1.29M |
|
|
BWIN
80
Baldwin Insurance Group
BWIN
$2.86B
| $1.38M | 0.63% |
+79,600
| New | +$961K |
|
|
VIE
81
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $1.35M | 0.62% |
+31,150
| New | +$1.41M |
|
|
API
82
Agora
API
$377M
| $1.32M | 0.61% |
+30,000
| New | +$1.42M |
|
83
Intellia Therapeutics
NTLA
$1.67B
| $1.3M | 0.6% |
+61,950
| New | +$1.05M |
|
84
Boston Scientific
BSX
$71.5B
| $1.3M | 0.59% |
+36,900
| New | +$1.33M |
|
85
Replimune Group
REPL
$1.01B
| $1.28M | 0.59% |
+51,498
| New | +$911K |
|
86
Legend Biotech
LEGN
$4.01B
| $1.28M | 0.59% |
+30,000
| New | +$1.17M |
|
87
argenx
ARGX
$54.1B
| $1.26M | 0.58% |
+5,600
| New | +$994K |
|
88
Dynatrace
DT
$14.2B
| $1.21M | 0.56% |
29,900
-35,200
| -54% | -$1.16M |
|
89
Cannae Holdings
CNNE
$649M
| $1.2M | 0.55% |
+29,150
| New | +$997K |
|
90
Appian
APPN
$2.48B
| $1.14M | 0.52% |
+22,200
| New | +$1.08M |
|
91
Fiverr
FVRR
$339M
| $1.11M | 0.51% |
+15,000
| New | +$771K |
|
92
Gossamer Bio
GOSS
$87M
| $1.1M | 0.5% |
+84,300
| New | +$1.06M |
|
93
RenaissanceRe
RNR
$13.4B
| $1.08M | 0.49% |
+6,300
| New | +$1.03M |
|
94
Iovance Biotherapeutics
IOVA
$2.87B
| $1.08M | 0.49% |
+39,200
| New | +$1.29M |
|
95
Vroom Inc
VRM
$48.2M
| $1.04M | 0.48% |
+250
| New | +$969K |
|
96
Reinsurance Group of America
RGA
$16.1B
| $977K | 0.45% |
+12,450
| New | +$1.15M |
|
|
NARI
97
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $969K | 0.44% |
+20,000
| New | +$955K |
|
|
RPTX
98
DELISTED
Repare Therapeutics
RPTX
| $924K | 0.42% |
+29,800
| New | +$957K |
|
|
AKUS
99
DELISTED
Akouos Inc
AKUS
| $905K | 0.41% |
+40,200
| New | +$896K |
|
100
BioCryst Pharmaceuticals
BCRX
$2.4B
| $866K | 0.4% |
+181,800
| New | +$726K |
|
Similar funds
FC
DTIM
NHSP
HCM
AEPIP
SAM
BI
MCAI
Pinz Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Pinz Capital Management held 227 positions worth $218M, up 472% from $38.2M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Pinz Capital Management deployed $158M of net new capital in Q2 2020, opening 105 new positions and adding to 2 existing holdings. Its largest new stake was T-Mobile US: 51,900 shares worth $5.41M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was CATALENT, INC., an estimated $1.78M trimmed.
- Pinz Capital Management's largest Q2 2020 buy was T-Mobile US: 51,900 shares worth $5.41M.
- Pinz Capital Management added most to Black Knight, Inc. Common Stock in Q2 2020, an estimated $3.01M increase.
- Pinz Capital Management's biggest Q2 2020 reduction was CATALENT, INC., cutting an estimated $1.78M.
- Pinz Capital Management fully exited eHealth in Q2 2020, selling an estimated $2.65M.
- Pinz Capital Management's ten largest holdings make up 19% of its $218M portfolio in Q2 2020.
- Pinz Capital Management opened 105 new positions and closed 116 in Q2 2020.
- Pinz Capital Management's portfolio value rose 472% quarter-over-quarter to $218M.
Based on Pinz Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.